The aim of the present study was to investigate the relationship between intramyocytic triglycerides levels, muscle TNF-a and GLUT4 expression and insulin resistance. METHODS: Insulin sensitivity was studied in 14 severely obese women (BMI > 40 kg=m 2 ), before and 6 months after low-dietary intake or bariatric malabsorptive surgery (bilio-pancreatic diversion, BPD), by the euglycaemic hyperinsulinaemic clamp technique, while the amount of intramyocytic triglycerides was chemically measured in needle muscle biopsies. Using reverse transcriptase-polymerase chain reaction analysis, the muscle mRNA expression of TNF-a and GLUT4 was also investigated. RESULTS: The weight loss after surgery was 25.98 AE 5.81 kg (P < 0.001), while that obtained with the diet was 5.07 AE 5.99 kg (P ¼ NS). Marked decrease in TNF-a mRNA levels (76.67 AE 12.59 to 14.01 AE 5.21 AU, P < 0.001) were observed in comparison with pre-treatment, whereas GLUT4 was significantly increased (62.25 AE 11.77 -124.25 AE 21.01 AU, P < 0.001) only in BPD patients. Increased glucose uptake (M) was accompanied by a significant decrease of TNF-a mRNA (76.67 AE 12.59 -14.01 AE 5.21 AU, P < 0.01) and an increase of GLUT4. The amounts of TNF-a mRNAs in skeletal muscle correlated inversely with GLUT4 mRNAs and directly with intramyocytic triglycerides levels. In a step-down regression analysis (r 2 ¼ 0.95) TNFa mRNA (P ¼ 0.0014), muscular TG levels (P ¼ 0.018), and GLUT4 mRNA (P ¼ 0.028) resulted to be the most powerful independent variables for predicting M values. CONCLUSION=INTERPRETATION: These findings suggest that insulin resistance in morbidly obese patients is positively associated to the intramyocytic triglycerides content and to TNF-a gene expression and inversely correlated to GLUT4 expression.
Introduction
The cytokine tumor necrosis factor-alpha (TNF-a) has been indicated as critical mediator in insulin resistance induction. Indeed, it shows a potent inhibitory effect on insulin signalling not only in the adipose tissue but also in isolated muscle cells. 1 In fact, it has been clearly demonstrated 2 that TNF-a is expressed in human muscle, and its level is higher in the muscle tissue of insulin-resistant and diabetic subjects. In these patients TNF-a expression was found to be four-fold higher than in insulin sensitive subjects, and a significant inverse linear relationship between maximal glucose disposal rate and muscle TNF-a was also shown. 2 By contrast, TNF-a concentration in the serum of both lean and obese subjects is very low, suggesting that TNF-a secreted by muscle cells 2 and adipocytes 1 acts in a paracrine manner. The finding that TNF-a expression is high in muscle and fat in obesity and diabetes led to the hypothesis that this may be a key factor in insulin resistance development. Support for this possibility comes from studies of genetically obese Zucker (fa=fa) rats in which systemic administration of monoclonal antibodies that neutralize TNF-a was able to reverse insulin resistance. 1 However, the administration of similar antibodies to subjects with type 2 diabetes did not result in any significant effect. 3 Recent studies demonstrated that TNF-a directly interferes with the insulin signaling cascade at an early step and thus impairs insulin-stimulated glucose transport, obesity being a state of TNF system overexpression. Such findings support the hypothesis that TNF-a is a mediator of obesity-linked insulin resistance. However, this concept is mainly based on animal data and is so far only partially supported by human studies.
Another important determinant of the insulin resistance state seems to be the level of intramyocytic triglycerides (TG). In fact, the skeletal muscle, which represents the principal site of insulin-mediated glucose disposal, 4 shows an increased content of triglycerides in obesity. 5, 6 In turn, both circulating 7 and muscle levels of triglycerides are strictly related to the whole body glucose uptake in an inverse fashion. 8 Furthermore, a marked lowering of plasma TG brough about by bariatric surgery (ie bilio-pancreatic diversion, BPD), which in all likelihood reflects the decrease of tissue TG levels, led to the reversibility of diabetes mellitus in two normal-weight young sisters with a genetic defect of lipoprotein lipase (LPL) activity and with ensuing chylomicronemia. 9, 10 The aim of the present study was to investigate the relationship between insulin sensitivity and GLUT4 and TNF-a expression in skeletal muscle of obese individuals before and after weight loss and to verify whether these values were related to the intramuscular TG levels. For this purpose we have studied a group of morbidly obese subjects before and after random assignment to either low-energy dietary regimen or bariatric surgery, which mainly induces fecal lipid malabsorption. Insulin sensitivity was studied, before and 6 months after the treatment, by euglycemic hyperinsulinemic clamp technique and the amount of intramyocytic TG was measured chemically in needle muscle biopsies.
Materials and methods

Subjects
The study groups consisted of 14 severely obese women (body mass index; BMI > 40 kg=m 2 ) studied twice: before and 6 months after hypocaloric diet or BPD operation. None had impaired glucose tolerance, diabetes mellitus or any other endocrine or non-endocrine disease. At the time of the baseline study, all subjects were on an ad libitun diet, with the following average composition: 60% carbohydrate, 30% fat, 10% protein (at least 1 g per kg of body weight). This dietary regimen was maintained for 1 week prior to the study. After the initial study, patients were randomized either to BPD (n ¼ 7, consisting of a partial gastrectomy with a distal Roux-en-Y reconstruction 11 or to a balanced, hypocaloric dietary regimen (1200 kcal daily). The study protocol was approved by the Institutional Ethical Committee of the Catholic University of Rome; the nature and purpose of the study were carefully explained to all subjects before they provided their written agreement to participate.
Body composition
At time 0 body weight was measured to the nearest 0.1 kg by a beam scale, and height to the nearest 0.5 cm using a stadiometer (Holatin, Crosswell, Wales, UK). Total body water (TBW) was determined using 0.19 Bq of tritiated water in 5 ml of saline solution administered as an intravenous bolus injection. 12 Blood samples were drawn before and 3 h after the injection. Radioactivity was determined in duplicate on 0.5 ml of plasma using a Beta-scintillation counter (Canberra-Packard, Model 1600TR, Meriden, CT, USA). Corrections were made (5%) for non-aqueous hydrogen exchange, 13 water density at body temperature was assumed to be 0.99371 kg=l. TBW; kg was computed as 3 H 2 O dilution space (liters)Â0.95Â0.99371. The within-subject CV for this method is 1.5%.
14 Fat-free mass (FFM) in kg was obtained by dividing the TBW by 0.732. 15 Euglycemic-hyperinsulinemic clamp procedure Peripheral insulin sensitivity was evaluated by the euglycemic-hyperinsulinemic clamp (EHC) procedure. 16 After inserting a cannula in a dorsal hand vein for sampling arterialized venous blood, and another one in the antecubital fossa of the contralateral arm for infusions, the subjects rested in a supine position for at least 1 h. They were placed with one hand warmed in a heated air box set at 60
C to obtain arterialized blood samples. Whole-body glucose uptake (M value) in mmol=kgFFM=min) was determined during a primed-constant infusion of insulin (at the rate of 7 pmol=min=kg). The fasting plasma glucose concentration was maintained throughout the insulin infusion by means of a variable glucose infusion and blood glucose determinations every 5 min. Whole-body peripheral glucose utilization was calculated during the last 40 min period of the steady-state insulin infusion.
Blood chemistry
Plasma glucose levels were measured by a glucose-oxidase method (Beckman, Fullerton, CA, USA). Plasma immunoreactive insulin was assayed using microparticle enzyme immunoassay (Abbott, Pasadena, CA, USA). Serum samples were assayed by an enzyme-linked immunosorbent method (Human TNF-a ELISA Kit, Fujirebio Co, Tokyo, Japan).
Muscle biopsy
Subjects were instructed not to perform physical exercise for 48 h before the muscle biopsy procedure, to help prevent the acute affects of exercise on muscle TG All subjects had fasted TNF-a and GLUT4 mRNAs correlate with muscle triglycerides G Mingrone et al overnight before biopsy. Biopsies were obtained under local anaesthesia from the vastus lateralis portion of the quadriceps femoris muscle. Tissue samples were immediately frozen in liquid nitrogen and stored at 7 80 C for further analysis of GLUT4 and TNF-a mRNA levels.
Skeletal muscle lipid analysis
To measure intracellular lipids a specimen of about 100 mg was taken and immediately placed into a calcium-free Hanks solution added with EDTA and bubbled with O 2 95% and CO 2 5%. The sample was washed and then immersed in a fresh Hanks solution added with collagenase type IV 50 mg and calcium ions and agitated in a Dubnoff water-bath maintained at 37 C until the tissue appeared soft. At this point the specimen was gently removed, cells were brushed with a blunted spatula, filtered, suspended in PBS and centrifuged twice at 50 g for 2 min. The supernatant was discarded and the muscle cells were dried under nitrogen stream. After protein precipitation with 5 -10 mg of trichloroacetic acid, lipids were extracted twice with 8 vols of chloroform-methanol (2:1, v=v) stirring the solutions at 60 C for 15 min. The combined extracts were dried in a GyroVap apparatus (GV1, Gio. DeVita, Rome, Italy) operating at 60 C, coupled with a vacuum pump and a gas trap (FTS System, Stone Ridge, NY, USA). The dry weight of lipid extracts was obtained by weighing the sample tube before and after drying the extracts. The above extracts were redissolved in chloroform-methanol (2:1, v=v) and fractionated into their various components by thin-layer chromatography (TLC) on standard thin layer plates (Stratocrom SI AP, Carlo Erba, Italy) coated with 0.25 mm thick layer of silica gel and activated by heating at 120 C for 20 min. The plates were developed into successive solvent system as described by Passi et al. 17 The area of silica gel corresponding to the R f of a triolein and tripalmitin standard mixture was scraped off and extracted with peroxide-free diethyl ether. The TG fraction eluted from the TLC plates was saponified by a treatment with 2 N KOH in methanol and successive acidification to pH 2 -3 with 2 N HCl. Free-fatty acids (FFA) were thus obtained and finally separated and measured according to a previous described method. 18 Recovery of glycerolmeasured enzymatically with a fuorimeter 19 in triplicate from tripalmitoyl-glycerol standard (Sigma Milan Chemical Co. Ltd) was 98 AE 3% (mean AE s.d.), and that from a tripalmitoylglycerol standard added to skeletal muscle cell samples was 95 AE 5%.
Semiquantitative reverse transcriptase-poymerase chain reaction (RT-PCR) Total cellular RNA was obtained from tissue biopsies using Trizol Reagent (Life Technology, Inc.). RNA was quantified spectrophotometrically. One microgram of RNA per sample was separated on an ethidium bromide-stained 1% agarose gel to assess its integrity. The yield of total RNA was 11 AE 3 mg per 100 mg.
The Perkin Elmer Gene Amp RNA PCR kit was used for all the RT-PCR reactions which were performed in the Gene Amp PCR System 9600 (Perkin Elmer Cetus, San Diego, CA, USA). After removal of contaminating chromosomal DNA with DNAse I treatment, 200 ng were reverse transcribed with 2.5 units of Moloney Murine Leukemia Virus Reverse Trancriptase (Promega, Madison, WI, USA) at 42 C for 30 min. Two microliters of cDNA products were used in each PCR reaction. The PCR reactions were carried out using different cycling parameters for each set of primers. The following primers were used for GLUT4: C and 1 min at 72 C was followed by 30 cycles of 45 s at 95 C, 45 s at 65 C and 1 min at 72 C. The myoglobulin was coamplified with target cDNAs using the primers at the final concentration of 0.24 mM. The number of cycles for the semiquantitative RT-PCR assay and the conditions of the reaction temperature were estimated to be optimal for a linear relationship between the amount of input template and the amounts of PCR product generated over a significant concentration range: 20 -100 ng from total RNA. PCR products were electrophoresed on a 2% agarose gel; images on the ethidium bromide-stained gels were acquired by a Cohu CCD camera and quantification was performed with Phoretix 1D (Phoretix International Ltd, Newcastle upon Tyne, UK).
Statistical analysis
All results are expressed as mean AE s.d. A Mann -Whitney test was used for between-group comparisons. Comparisons of values at the beginning of the study and after 6 months from starting the treatment in each patient were done using a Wilcoxon test. Spearman correlation coefficients and regression analyses were used to examine association of M with other variables. Multiple linear regression analysis TNF-a and GLUT4 mRNAs correlate with muscle triglycerides G Mingrone et al (method stepwise) was performed to identify the best predictors of the M values using the independent variables, intramyocytic TG, GLUT4 mRNA, TNF-a mRNA, BMI, FFM and FM.
Results were considered significant at the P 0.05 level.
Results Table 1 reports the anthropometric variables before and after hypocaloric diet or BPD. The weight loss observed over a 6-months period was significantly greater in the severely obese subjects who underwent BPD than that found in the obese group treated with hypoenergetic diet (26.0 AE 5.8 vs 5.1 AE 4.0 kg; P < 0.0001) due to a low compliance to the diet. A significant reduction of FM was observed only in the BPD group (from 53.8 AE 12.3 to 41.3 AE 9.5 kg; P < 0.01) together with a significant reduction of FFM. Fasting plasma FFA, TG and insulin are reported in Table 1 .
The target plasma glucose concentration in the two groups of subjects studied before and after diet or bariatric surgery was not statistically different inside each group examined. In all patients the plasma glucose concentration variation in the last 40 min of the 2 h clamp was lower than 10% and a steady-state glucose infusion rate was always achieved in the last 40 min of the EHC. The M value about doubled after surgery (30.8 AE 9.6 vs 61.2 AE 11.3 mmol= kg FFM =min; P ¼ 0.001) becoming similar to the values currently reported for healthy subjects in the literature; 20 no significant variation of M value was observed after hypoenergetic diet (45.7 AE 8.8 vs 36.6 AE 10.5 mmol=kg FFM =min). Similar results were obtained by using the ratio M=l, which is obtained by dividing the average value of M, calculated over the last 40 min of the clamp, by the value of plasma insulin averaged on the same period (0.061 AE 0.010 vs 0.035 AE 0.005 mmol=kg FFM =min=pmol in BPD P < 0.001 and 0.038 AE 0.008 vs 0.032 AE 0.010 mmol=kg FFM =min=pmol in diet; P ¼ NS). The average plasma insulin levels during the last 40 min of the clamp were not statistically different in the two groups; nevertheless, the lowest value reached was 480 pM, so that it is conceivable that the hepatic glucose production was inhibited by insulin.
The intramyocytic level of TG significantly (P < 0.001) decreased after BPD operation (from 3.5 AE 0.4 to 2.1 AE 0.3 mg%), while it remained unchanged in the diettreated group (from 3.2 AE 0.8 to 2.9 AE 0.4 mg%, P ¼ NS).
TNF-a, GLUT4 and myoglobulin mRNAs, were detected in all the muscle samples examined. Mock RT-PCR (without reverse transcriptase) produced no bands, demonstrating the absence of contamining genomic DNA. To verify whether the detection of TNF-a mRNA did not result from contamination of the biopsies with fat cells, total RNA preparations from muscle were examined for leptin mRNA expression using a previously described method. 21 Leptin mRNA was undetectable, thus indicating the absence of measurable contamination of the muscle with adipocytes. Figure 1 shows a marked decrease of TNF-a mRNA levels before and after BPD operation (from 76.7 AE 12.6 to 14.0 AE 5.2 AU, P < 0.01), while the relative amount of TNF-a was unchanged after diet (76.6 AE 7.8 to 68.5 AE 10.4, P ¼ NS). In contrast, the level of GLUT4 mRNA ( Figure 2 ) was significantly increased after BPD (62.2 AE 11.8 to 124.2 AE 21.0 AU, P < 0.001); in spite of a trend toward an increment of glucose transporters, no significant differences were observed in the diet-treated group (60.5 AE 9.9 to 75.5 AE 14.0, P ¼ NS).
Comparison of DTNF-a mRNA in skeletal muscle and the variation of glucose uptake values showed a negative linear correlation (y ¼ 7 23.842x þ 1.3793; r 2 ¼ 0.92; P < 0.0001). DGLUT4 mRNA levels were positively correlated with the changes in whole body glucose uptake (y ¼ 0.0357x þ 0.0344; r 2 ¼ 0.84; P < 0.0001). On the contrary, a reduction in TG muscle content was related to an increase of the tissue glucose uptake (y ¼ 7 9.4741x þ 1.8485; r 2 ¼ 0.88). Figure 3 shows the correlation between percentage changes in TNFa mRNA and GLUT4 mRNA levels in the skeletal muscle biopsies (y ¼ 7 0.7431x, r 2 ¼ 0.92; P < 0.0001). P < 0.01, *P < 0.001 and **P < 0.0001: significance between pre-and post-treatment in the BPD group. { P < 0.01, § P < 0.001 and § § P < 0.0001: significance between BPD and diet treated groups after the treatment.
TNF-a and GLUT4 mRNAs correlate with muscle triglycerides G Mingrone et al
Intramyocytic DTG levels were significantly correlated with DTNFa mRNA levels (y ¼ 1.5782x 7 27.051, r 2 ¼ 0.85; P < 0.0001; Figure 4) .
A step-down regression analysis (r 2 ¼ 0.95) was used to evaluate the joint effect of intramyocytic TG levels, TNFa mRNA and GLUT4 mRNA, BMI, FFM and FM on the whole body glucose uptake; TNFa mRNA (P ¼ 0.0014), muscular TG levels (P ¼ 0.018), and GLUT4 mRNA (P ¼ 0.028) were the most powerful independent variables for predicting M values.
Therefore, the marked improvement of the amount of glucose taken up by tissues during EHC in BPD patients was accompanied by increased expression of GLUT coupled with decreased TG as well as TNF-a mRNA concentrations. However, the levels of mRNA for TNF-a and GLUT4 were not significantly related. The ELISA measurements of TNF-a in TNF-a and GLUT4 mRNAs correlate with muscle triglycerides G Mingrone et al both serum and skeletal muscle specimens were below the sensitivity limit for the kit used.
Discussion
The present study provides new insights into the mechanisms of insulin resistance in obesity. Our data indicate that skeletal muscle TNFa expression is significantly reduced in post-obese subjects and it is associated with a simultaneous increase in muscle GLUT4 mRNA and that a significant correlation between TNFa mRNA and intramyocytic triglycerides changes exists. Furthermore, the increased glucose disposal rate found during the euglycaemic hyperinsulinaemic clamp clearly indicates that the whole body insulin sensitivity is increased after bariatric surgery in parallel to a lower triglyceride content in muscles, 22 in agreement with Randle's hypothesis of glucose=fatty acid fuel competition. 23 A number of molecular mechanisms may be involved in the marked improvement of the glucose disposal in BPD patients. Firstly, GLUT4 mRNA levels were increased in skeletal muscle of the subjects who had undergone BPD, and TNF-a gene expression was considerably decreased. These findings are relevant and are in line with the observation that TNF-a expression was found to be elevated in the subcutaneous fat of insulin-resistant humans 24 when lipid availability as fuel substrates was larger than normal. 25 On the other hand, it must be kept in mind that circulating TNFa in insulin-resistant obese subjects was undetectable in different clinical studies 26, 27 and this may raise the question as to whether adipose-released TNF-a is really able to affect the muscle metabolism.
Our findings that a decrease in the intramuscular lipid depot is directly correlated to a lower TNF-a mRNA level in muscle suggests that changes in the TNF-a concentration may act in a paracrine way in this tissue. Another observation which demonstrates an inverse linear relationship between the maximum glucose disposal rate and muscle TNF-a further points to the critical role of this mediator in the development of insulin resistance.
2 This is consistent with the finding that, in muscle biopsies of patients with gastrointestinal cancer, TNF-a production is increased, and the degree of insulin sensitivity correlates negatively with TNF-a and GLUT4 mRNAs correlate with muscle triglycerides G Mingrone et al TNF-a, and positively with GLUT4 mRNA levels. 28 Furthermore, numerous animal models of obesity and insulin resistance based on spontaneous genetic mutations or experimentally created gene deletions have been investigated to clarify the molecular mechanisms and role of different signal pathways and molecules involved in the development of these diseases. 29 -31 Also in these models it has been shown that TNF-a negatively interferes with insulin receptor signaling, 32, 33 while, on the other hand, obese mice with a targeted null mutation in the gene encoding TNFa and those encoding the two receptors for TNFa showed a significant improved insulin sensitivity. 34 These mice had lower levels of circulating FFA, and were protected from the obesity-related reduction in the insulin receptor signaling in muscle and fat tissues. 34 Finally, TNFa knockout mice have more GLUT4 protein expressed in muscle tissue. 35 TNF-a expression is usually increased in adipose tissue and skeletal muscle of obese diabetic patients, 2, 24 together with lipid metabolism alterations in these tissues. 36 Our findings suggest that normalizing the lipid content inside muscles may restore the utilization of carbohydrates as the muscular, preferential fuel substrate. This may be, at least in part, due to the inhibition of TNF-a and the induction of GLUT4 gene expression. This interpretation of the present data is also supported by recent studies of our group, 21 which reported a marked increase in TNF-a associated with depression of GLUT4 gene expression in red fiber-type muscle of rats when the availability of circulating lipids was increased. It seems that in these experimental conditions 21 a selective insulin resistance develops in muscle. Furthermore, it has been shown that, in human fetal intestinal epithelial cells, TNF-a expression is regulated by long chain fatty acids (LCFA) and that both medium chain fatty acids (MCFA) and LCFA significantly enhance IL-1ß and TNF-a after IL-8 challenge. 37 It is likely, therefore, that LCFA intramyocytic level regulates TNF-a production such as in intestinal cells.
In conclusion, these data show that TNF-a gene expression is correlated directly to the intramyocytic level of TG and indirectly to the GLUT4 gene expression. On the basis of these results it might be suggested that insulin resistance in morbidly obese patients is linked to the down-regulation of GLUT4 synthesis and, possibly, to the suppression of tyrosine phosphokinase via increased skeletal muscle TNF-a levels, while the restoration of a near-normal glucose uptake after malabsorptive surgery might be a consequence of the inhibition of TNF-a gene expression deriving from the intramyocytic lowering of TG.
